Building a Pipeline of Therapies to Treat Rare Mineralization Disorders

RARECast - Podcast tekijän mukaan RARECast - Torstaisin

kokeile Podimo ilmaiseksi 90!!! päivän ajan

kokeile Podimo ilmaiseksi 90!!! päivän ajan

universumia joka on täynnä satoja podcasteja ja äänikirjoja, klikkaa tätä kokeillaksesi

 Sponsored
Podcast artwork

Kategoriat:

Talous

Axel Bolte, co-founder and CEO of Inozyme, discusses ENPP1 deficiency, the company's lead experimental therapy to treat the condition, and its work with Rady Children’s Institute for Genomic Medicine to improve the diagnosis of newborns with the disease.

Visit the podcast's native language site